Viral Safety: The AFSSAPS Speaks Out About the Regulatory Environment




Pharmaceuticals & Biotechnology | Pharma & Biotech Resources show

Summary: Contaminations in biological products in 2009 and the porcine circovirus contamination of GSK’s Rotarix vaccine in March of this year has highlighted the issue of viral safety in biologics more than ever before. Marc Martin, Viral Safety Assessor at AFSSAPS, joins Helen Winsor from